Semler Scientific, Nasdaq-Listed Biotech Firm, Considers Selling Shares to Buy More Bitcoin

IconCryptoNewsTerminal Staff26 Jul, 2024

cryptonews.jpg

Semler Scientific, Nasdaq-Listed Biotech Firm, Considers Selling Shares to Buy More Bitcoin

Semler Scientific (SMLR), a Nasdaq-listed biotech firm, is considering selling shares to acquire more Bitcoin, according to Bitcoin Magazine. This news follows the company's announcement in May 2023, when it disclosed an investment of $40 million in Bitcoin, making it a primary treasury asset. Semler Scientific's move reflects the growing acceptance of Bitcoin as a legitimate investment vehicle among institutional investors. Selling shares to purchase Bitcoin demonstrates Semler Scientific's commitment to diversifying its portfolio and potentially benefiting from Bitcoin's long-term growth prospects.